Literature DB >> 15926190

Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm.

Bernard Portha1.   

Abstract

Now that the reduction in beta-mass has been clearly established in humans with type 2 diabetes mellitus (T2DM) 1-4, the debate focuses on the possible mechanisms responsible for decreased beta-cell number and impaired beta-cell function and their multifactorial etiology. Appropriate inbred rodent models are essential tools for identification of genes and environmental factors that increase the risk of abnormal beta-cell function and of T2DM. The information available in the Goto-Kakizaki (GK) rat, one of the best characterized animal models of spontaneous T2DM, are reviewed in such a perspective. We propose that the defective beta-cell mass and function in the GK model reflect the complex interactions of three pathogenic players: (1) several independent loci containing genes causing impaired insulin secretion; (2) gestational metabolic impairment inducing a programming of endocrine pancreas (decreased beta-cell neogenesis) which is transmitted to the next generation; and (3) secondary (acquired) loss of beta-cell differentiation due to chronic exposure to hyperglycemia (glucotoxicity). An important message is that the 'heritable' determinants of T2DM are not simply dependant on genetic factors, but probably involve transgenerational epigenetic responses. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15926190     DOI: 10.1002/dmrr.566

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  39 in total

1.  Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat.

Authors:  Li Shen; Michael J Keenan; Anne Raggio; Cathy Williams; Roy J Martin
Journal:  Mol Nutr Food Res       Date:  2011-06-03       Impact factor: 5.914

2.  Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Authors:  Martine Desrois; Kieran Clarke; Carole Lan; Christiane Dalmasso; Mark Cole; Bernard Portha; Patrick J Cozzone; Monique Bernard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

Review 3.  What is an epigenetic transgenerational phenotype? F3 or F2.

Authors:  Michael K Skinner
Journal:  Reprod Toxicol       Date:  2007-09-11       Impact factor: 3.143

Review 4.  Small G proteins in islet beta-cell function.

Authors:  Anjaneyulu Kowluru
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  Epigenetics in mammary gland biology and cancer.

Authors:  Eve Devinoy; Monique Rijnkels
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-03       Impact factor: 2.673

6.  Up-regulation of stearoyl-CoA desaturase 1 increases liver MUFA content in obese Zucker but not Goto-Kakizaki rats.

Authors:  Minako Karahashi; Fumiko Ishii; Tohru Yamazaki; Koichi Imai; Atsushi Mitsumoto; Yoichi Kawashima; Naomi Kudo
Journal:  Lipids       Date:  2013-03-29       Impact factor: 1.880

7.  Ranking candidate genes in rat models of type 2 diabetes.

Authors:  Lars Andersson; Greta Petersen; Fredrik Ståhl
Journal:  Theor Biol Med Model       Date:  2009-07-03       Impact factor: 2.432

8.  Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages.

Authors:  Wen-Jun Deng; Song Nie; Jie Dai; Jia-Rui Wu; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2009-08-23       Impact factor: 5.911

Review 9.  Effects of diabetes on hippocampal neurogenesis: links to cognition and depression.

Authors:  Nancy Ho; Marilyn S Sommers; Irwin Lucki
Journal:  Neurosci Biobehav Rev       Date:  2013-05-13       Impact factor: 8.989

10.  Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats.

Authors:  Hyejin Jeong; Hye Jin Kwon; Mi Kyung Kim
Journal:  Nutr Res Pract       Date:  2009-03-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.